MediWound (MDWD) EBITDA Margin Growth (3y) (2017 - 2025)

MediWound (MDWD) EBITDA Margin Growth (3y) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 -37,575.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -37,575.00
Sep 30, 2025 -5,638.00
Jun 30, 2025 -10,575.00
Mar 31, 2025 -4,221.00
Dec 31, 2024 -3,126.00
Sep 30, 2024 2,471.00
Jun 30, 2024 -17,324.00
Mar 31, 2024 1,880.00
Dec 31, 2023 -3,422.00
Sep 30, 2023 -439.00
Jun 30, 2023 -6,565.00
Mar 31, 2023 -4,090.00
Dec 31, 2022 7,374.00
Sep 30, 2022 1,048.00
Jun 30, 2022 -177,745.00
Mar 31, 2022 80,509.00
Dec 31, 2021 -5,184.00
Sep 30, 2021 16,645.00
Jun 30, 2021 21,803.00
Mar 31, 2021 63,794.00